ANI Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.About ANIP
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments.
ANIP Key Statistics
Stock Snapshot
ANI Pharmaceuticals(ANIP) stock is priced at $75.60, giving the company a market capitalization of 1.7B. It carries a P/E multiple of 23.02.
On 2026-03-05, ANI Pharmaceuticals(ANIP) stock moved within a range of $74.82 to $76.16. With shares now at $75.60, the stock is trading +1.0% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 289.62K, compared to an average daily volume of 407.93K.
Over the past 52 weeks, ANI Pharmaceuticals(ANIP) stock has traded between a high of $99.50 and a low of $56.71.
Over the past 52 weeks, ANI Pharmaceuticals(ANIP) stock has traded between a high of $99.50 and a low of $56.71.
ANIP News
An update from ANI Pharmaceuticals ( (ANIP) ) is now available. On March 3, 2026, President and CEO Nikhil Lalwani and ANI Pharmaceuticals’ executive team were...
Ani Pharmaceuticals ((ANIP)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level...
In late February 2026, ANI Pharmaceuticals, Inc. reported past fourth-quarter 2025 sales of US$247.06 million and net income of US$27.49 million, alongside full...
Analyst ratings
88%
of 8 ratingsMore ANIP News
ANI Pharmaceuticals Inc. (NASDAQ:ANIP) shares are down early Friday following the company’s strong fourth-quarter report. ANI Pharmaceuticals reported adjusted...
(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Friday a net income attributable to common shareholders for the fourth quarter o...
Reports Q4 revenue $247.1M, consensus $231.03M. “2025 was a year of significant growth for our Rare Disease and Generics businesses, which drove expansion to bo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.